Sage Licenses 300+ Journals to OpenEvidence for AI-Powered Clinical…

Event summary

Sage has licensed its portfolio of 300+ peer-reviewed journals to OpenEvidence, integrating the content into OpenEvidence's AI platform for clinicians.
The partnership aims to reduce the time it takes for research to reach clinical practice, addressing the gap between publication and application.
OpenEvidence, used by 60% of U.S. physicians, will now surface Sage's research alongside existing peer-reviewed literature, with direct citations to original articles.
Sage's content includes journals from key medical societies such as the American Orthopaedic Society for Sports Medicine and the World Stroke Organization.
The agreement provides Sage with direct access to the clinical questions physicians are asking daily.

The big picture

The partnership between Sage and OpenEvidence addresses the critical gap in the healthcare industry where the volume of medical research outpaces clinicians' ability to stay updated. By integrating Sage's peer-reviewed content into OpenEvidence's AI platform, the deal aims to streamline the dissemination of research, potentially improving clinical decision-making. This collaboration highlights the growing trend of leveraging AI to enhance the efficiency and effectiveness of medical research utilization.

What we're watching

Adoption Dynamics: How the integration of Sage's content will affect OpenEvidence's user engagement and retention among clinicians.
Content Expansion: Whether OpenEvidence can sustain its growth by continuously adding high-quality, peer-reviewed content from other publishers.
Clinical Impact: The pace at which this partnership will reduce the time it takes for research to be applied in clinical practice.